Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2020-06-30
Original SEC Filing: Click here

---

Webplus: SVA/20200630/6-K/2_EX-99.1/000.htm SEC Original: tm2023782d1_ex99-1.htm
Sinovac Reports Unaudited First Quarter 2020 Financial Results BEIJING, China, June 30, 2020 / Business Wire/ — Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today its unaudited financial results for the first quarter ended March 31, 2020. First Quarter of 2020 Financial Summary Ÿ Sales for the first quarter

---

---

Webplus: SVA/20200630/6-K/1/000.htm SEC Original: tm2023782d1_6k.htm

---

Company Info:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2020-06-30CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 15 ZHI TONG ROAD,, ZHONGGUANCUN TECH PARK, CHANGPING DISTR.
BEIJING 102200